Pharmacological blockade of 5-HT 7 receptors as a putative fast acting antidepressant strategy

Neuropsychopharmacology

Volumn 36, Issue 6, 2011, Pages 1275-1288

  Mnie Filali, Ouissame ^a   Faure, Céline ^a   Lambás Sẽas, Laura ^a   Mansari, Mostafa El ^b   Belblidia, Hassina ^a   Gondard, Elise ^a   Etiévant, Adeline ^a   Scarna, Hélène ^a   Didier, Anne ^a   Berod, Anne ^a   Blier, Pierre ^b   Haddjeri, Nasser ^a  

^a UNIVERSITÉ LYON 1   (France)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

5 HT receptors; antidepressant; anxiety; dorsal raphe; mood; neurogenesis

Indexed keywords

3 [2 [2 (4 METHYL 1 PIPERIDINYL)ETHYL] 1 PYRROLIDINESULFONYL]PHENOL; AUTORECEPTOR; FENCLONINE; FLUOXETINE; SEROTONIN 7 RECEPTOR;

ADULTHOOD; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; DESENSITIZATION; DORSAL RAPHE NUCLEUS; DRUG EFFECT; DRUG MECHANISM; FEMALE; HIPPOCAMPUS; IN VIVO STUDY; MALE; NERVE CELL; NONHUMAN; OLFACTORY BULBECTOMY; OPEN FIELD BEHAVIOR; OPEN FIELD TEST; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING;

ANIMALS; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER; DISEASE MODELS, ANIMAL; MALE; PHENOLS; RATS; RATS, SPRAGUE-DAWLEY; REACTION TIME; RECEPTORS, SEROTONIN; SEROTONIN ANTAGONISTS; SULFONAMIDES;

EID: 79954597841     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/npp.2011.13     Document Type: Article

References (103)

1. Abbas AI, Hedlund PB, Huang XP, Tran TB, Meltzer HY, Roth BL (2009). Amisulpride is a potent 5-HT7 antagonist: relevance for antidepressant actions in vivo. Psychopharmacology 205: 119-128.
2. Aghajanian GK, Vandermaelen CP (1982). Intracellular recordings from serotonergic dorsal raphe neurons: pacemaker potentials and the effect of LSD. Brain Res 238: 463-469. (Pubitemid 12156260)
3. Alexandre C, Popa D, Fabre V, Bouali S, Venault P, Lesch KP et al (2006). Early life blockade of 5-hydroxytryptamine 1A receptors normalizes sleep and depression-like behavior in adult knockout mice lacking the serotonin transporter. J Neurosci 26: 5554-5564. (Pubitemid 44318406)
4. Andersen SL, Dumont NL, Teicher MH (2002). Differences in behavior and monoamine laterality following neonatal clomi-pramine treatment. Dev Psychobiol 41: 50-57. (Pubitemid 34670641)
5. Ansorge MS, Zhou M, Lira A, Hen R, Gingrich JA (2004). Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice. Science 306: 879-881. (Pubitemid 39446998)
6. Banasr M, Hery M, Brezun JM, Daszuta A (2001). Serotonin mediates oestrogen stimulation of cell proliferation in the adult dentate gyrus. Eur J Neurosci 14: 1417-1424. (Pubitemid 35463709)
7. Bel N, Artigas F (1992). Fluvoxamine preferentially increases extracellular 5-hydroxytryptamine in the raphe nuclei: an in vivo microdialysis study. Eur J Pharmacol 229: 101-103.
8. Berman RM, Fava M, Thase ME, Trivedi MH, Swanink R, McQuade RD et al (2009). Aripiprazole augmentation in major depressive disorder: a double-blind, placebo-controlled study in patients with inadequate response to antidepressants. CNS Spectr 14: 197-206.
9. Bessa JM, Ferreira D, Melo I, Marques F, Cerqueira JJ, Palha JA et al (2009). The mood-improving actions of antidepressants do not depend on neurogenesis but are associated with neuronal remodeling. Mol Psychiatry 14: 764-773.
10. Besson A, Haddjeri N, Blier P, de Montigny C (2000). Effects of the combination of mirtazapine and paroxetine on the 5-HT neurotransmission. Eur Neuropsychopharmacol 10: 177-188. (Pubitemid 30227618)
11. Blier P, de Montigny C, Tardif D (1984). Effects of the two antidepressant drugs mianserin and indalpine on the serotoner-gic system: single-cell studies in the rat. Psychopharmacology (Berl) 84: 242-249. (Pubitemid 14006580)
12. Blier P, de Montigny C (1987). Modification of 5-HT neuron properties by sustained administration of the 5-HT1A agonist gepirone: electrophysiological studies in the rat brain. Synapse 1: 470-480.
13. Blier P, de Montigny C (1994). Current advances and trends in the treatment of depression. Trends Pharmacol Sci 15: 220-226. (Pubitemid 24210726)
14. Blier P, de Montigny C (1999). Serotonin and drug-induced therapeutic responses in major depression, obsessive-compulsive and panic disorders. Neuropsychopharmacology 21: 91S-98S. (Pubitemid 29396476)
15. Bonaventure P, Kelly L, Aluisio L, Shelton J, Lord B, Galici R et al (2007). Selective blockade of 5-hydroxytryptamine (5-HT)7 receptors enhances 5-HT transmission, antidepressant-like behavior, and rapid eye movement sleep suppression induced by citalopram in rodents. J Pharmacol Exp Ther 321: 690-698. (Pubitemid 46624521)
16. Breuer ME, Groenink L, Oosting RS, Westenberg HG, Olivier B (2007). Long-term behavioral changes after cessation of chronic antidepressant treatment in olfactory bulbectomized rats. Biol Psychiatry 61: 990-995. (Pubitemid 46482465)
17. Burghardt NS, Bush DE, McEwen BS, LeDoux JE (2007). Acute selective serotonin reuptake inhibitors increase conditioned fear expression: blockade with a 5-HT(2C) receptor antagonist. Biol Psychiatry 62: 1111-1118. (Pubitemid 350029715)
18. Cairncross KD, Wren A, Forster C, Cox B, Schnieden H (1979). The effect of psychoactive drugs on plasma corticosterone levels and behaviour in the bulbectomized rat. Pharmacol Biochem Behav 10: 355-359. (Pubitemid 9180870)
19. Castrén E (2004). Neurotrophic effects of antidepressant drugs. Curr Opin Pharmacol 4: 58-64. (Pubitemid 38145839)
20. Chaput Y, Blier P, de Montigny C (1986). In vivo electrophysio-logical evidence for the regulatory role of autoreceptors on serotonergic terminals. J Neurosci 6: 2796-2801. (Pubitemid 16026058)
21. Czachura JF, Rasmussen K (2000). Effects of acute and chronic administration of fluoxetine on the activity of serotonergic neurons in the dorsal raphe nucleus of the rat. Naunyn Schmiedebergs Arch Pharmacol 362: 266-275.
22. Dekeyne A, Denorme B, Monneyron S, Millan MJ (2000). Citalopram reduces social interaction in rats by activation of serotonin (5-HT)(2C) receptors. Neuropharmacology 39: 1114-1117. (Pubitemid 30155720)
23. De Montigny C, Chaput Y, Blier P (1990). Modification of serotonergic neuron properties by long-term treatment with serotonin reuptake blockers. J Clin Psychiatry 51(Suppl B): 4-8.
24. Duman RS, Nakagawa S, Malberg J (2001). Regulation of adult neurogenesis by antidepressant treatment. Neuropsychopharma-cology 25: 836-844. (Pubitemid 34031890)
25. El Mansari M, Sánchez C, Chouvet G, Renaud B, Haddjeri N (2005). Effects of acute and long-term administration of escitalopram and citalopram on serotonin neurotransmission: an in vivo electrophysiological study in rat brain. Neuropsycho-pharmacology 30: 1269-1277. (Pubitemid 40848081)
26. Faure C, Mnie-Filali O, Haddjeri N (2006a). Long-term adaptive changes induced by serotonergic antidepressant drugs. Expert Rev Neurother 6: 235-245.
27. Faure C, Mnie-Filali O, Scarna H, Debonnel G, Haddjeri N (2006b). Effects of the 5-HT7 receptor antagonist SB-269970 on rat hormonal and temperature responses to the 5-HT1A/7 receptor agonist 8-OH-DPAT. Neurosci Lett 404: 122-126. (Pubitemid 44041780)
28. Fu Y, Zhu ZT, Chen LJ, Yu LP, Jin GZ (2000). Behavioral characteristics of olanzapine: an atypical neuroleptic. Acta Pharmacol Sin 21: 329-334. (Pubitemid 30220139)
29. González-Maeso J, Yuen T, Ebersole BJ, Wurmbach E, Lira A, Zhou M et al (2003). Transcriptome fingerprints distinguish hallucinogenic and nonhallucinogenic 5-hydroxytryptamine 2A receptor agonist effects in mouse somatosensory cortex. J Neurosci 23: 8836-8843. (Pubitemid 37210895)
30. Greenwood BN, Strong PV, Brooks L, Fleshner M (2008). Anxietylike behaviors produced by acute fluoxetine administration in male Fischer 344 rats are prevented by prior exercise. Psychopharmacology (Berl) 199: 209-222.
31. Guscott M, Bristow LJ, Hadingham K, Rosahl TW, Beer MS, Stanton JA et al (2005). Genetic knockout and pharmacological blockade studies of the 5-HT7 receptor suggest therapeutic potential in depression. Neuropharmacology 48: 492-502. (Pubitemid 40332407)
32. Haddjeri N, Blier P (1995). Pre- and post-synaptic effects of the 5-HT3 agonist 2-methyl-5-HT on the 5-HT system in the rat brain. Synapse 20: 54-67.
33. Haddjeri N, Blier P, de Montigny C (1998a). Long-term antidepressant treatments result in a tonic activation of forebrain 5-HT1A receptors. J Neurosci. 18: 10150-10156. (Pubitemid 28543788)
34. Haddjeri N, de Montigny C, Curet O, Blier P (1998b). Effects of sustained administration of the reversible monoamine oxidase-A inhibitor befloxatone on the 5-HT neurotransmission. Eur J Pharmacol 343: 179-192.
35. Haddjeri N, Faure C, Lucas G, Mnie-Filali O, Chouvet G, Astier B et al (2004). In-vivo modulation of central 5-hydroxytryptamine (5-HT1A) receptor-mediated responses by the cholinergic system. Int J Neuropsychopharmacol 7: 391-399. (Pubitemid 39648069)
36. Haddjeri N, Szabo ST, de Montigny C, Blier P (2000). Increased tonic activation of rat forebrain 5-HT(1A) receptors by lithium addition to antidepressant treatments. Neuropsychopharmacol-ogy 22: 346-356. (Pubitemid 30105763)
37. Halim ND, Weickert CS, McClintock BW, Weinberger DR, Lipska BK (2004). Effects of chronic haloperidol and clozapine treatment on neurogenesis in the adult rat hippocampus. Neuropsychopharmacology 29: 1063-1069. (Pubitemid 38670044)
38. Hansen HH, Sánchez C, Meier E (1997). Neonatal administration of the selective serotonin reuptake inhibitor Lu 10-134-C increases forced swimming-induced immobility in adult rats: a putative animal model of depression? J Pharmacol Exp Ther 283: 1333-1341. (Pubitemid 28016508)
39. Harsing Jr LG, Prauda I, Barkoczy J, Matyus P, Juranyi Z (2004). A 5-HT7 heteroreceptor-mediated inhibition of [3H]serotonin release in raphe nuclei slices of the rat: evidence for a serotonergic-glutamatergic interaction. Neurochem Res 29: 1487-1497. (Pubitemid 38860229)
40. Hedlund PB, Kelly L, Mazur C, Lovenberg T, Sutcliffe JG, Bonaventure P (2004). 8-OH-DPAT acts on both 5-HT1A and 5-HT7 receptors to induce hypothermia in rodents. Eur J Pharmacol 487: 125-132. (Pubitemid 38368989)
41. Hedlund PB (2009). The 5-HT7 receptor and disorders of the nervous system: an overview. Psychopharmacology (Berl) 206: 345-354.
42. Hedlund PB, Huitron-Resendiz S, Henriksen SJ, Sutcliffe JG (2005). 5-HT7 receptor inhibition and inactivation induce antidepres-sant-like behavior and sleep pattern. Biol Psychiatry 58: 831-837. (Pubitemid 41677422)
43. Hedlund PB, Sutcliffe JG (2004). Functional, molecular and pharmacological advances in 5-HT7 receptor research. Trends Pharmacol Sci 25: 481-486. (Pubitemid 39149704)
44. Hensler JG (2002). Differential regulation of 5-HT1A receptor-G protein interactions in brain following chronic antidepressant administration. Neuropsychopharmacology 26: 565-573. (Pubitemid 34260975)
45. Hilakivi LA, Hilakivi I (1987). Increased adult behavioral 'despair' in rats neonatally exposed to desipramine or zimeldine: an animal model of depression? Pharmacol Biochem Behav 28: 367-369. (Pubitemid 18002786)
46. Hyttel J, B0ges0 KP, Perregaard J, Sanchez C (1992). The pharmacological effect of citalopram residues in the (S)-(+)-enantiomer. J Neural Transm Gen Sect 88: 157-160.
47. Jha S, Rajendran R, Davda J, Vaidya VA (2006). Selective serotonin depletion does not regulate hippocampal neurogenesis in the adult rat brain: differential effects of p-chlorophenylalanine and 5,7-dihydroxytryptamine. Brain Res 1075: 48-59.
48. Kandel ER, Spencer WA (1961). Electrophysiology of hippocampal neurons. II. After potentials and repetitive firing. J Neurophysiol 24: 243-259.
49. Karpova NN, Lindholm J, Pruunsild P, Timmusk T, Castren E (2009). Long-lasting behavioural and molecular alterations induced by early postnatal fluoxetine exposure are restored by chronic fluoxetine treatment in adult mice. Eur Neuropsycho-pharmacol 19: 97-108.
50. Kim HS, Park IS, Park WK (1998). NMDA receptor antagonists enhance 5-HT2 receptor-mediated behavior, head-twitch response, in mice. Life Sci 63: 2305-2311.
51. Kitaichi K, Yamada K, Hasegawa T, Furukawa H, Nabeshima T (1994). Effects of risperidone on phencyclidine-induced behaviors: comparison with haloperidol and ritanserin. Jpn J Pharmacol 66: 181-189. (Pubitemid 24357099)
52. Kodama M, Fujioka T, Duman RS (2004). Chronic olanzapine or fluoxetine administration increases cell proliferation in hippocampus and prefrontal cortex of adult rat. Biol Psychiatry 56: 570-580. (Pubitemid 39336404)
53. Kuhn HG, Dickinson-Anson H, Gage FH (1996). Neurogenesis in the dentate gyrus of the adult rat: age-related decrease of neuronal progenitor proliferation. J Neurosci 16: 2027-2033. (Pubitemid 26144015)
54. Lanfumey L, Hamon M (2004). 5-HT1 receptors. CurrDrug Targets CNS Neurol Disord 3: 1-10.
55. Laplante P, Diorio J, Meaney MJ (2002). Serotonin regulates hippocampal glucocorticoid receptor expression via a 5-HT7 receptor. Brain Res Dev Brain Res 139: 199-203. (Pubitemid 35453906)
56. Le Poul E, Laaris N, Doucet E, Laporte AM, Hamon M, Lanfumey L (1995). Early desensitization of somato-dendritic 5-HT1A autoreceptors in rats treated with fluoxetine or paroxetine. Naunyn Schmiedebergs Arch Pharmacol 352: 141-148.
57. Lucas G, Rymar VV, Du J, Mnie-Filali O, Bisgaard C, Manta S et al (2007). Serotonin (5-HT(4)) receptor agonists are putative antidepressants with a rapid onset of action. Neuron 55: 712-725. (Pubitemid 47334877)
58. Maciag D, Williams L, Coppinger D, Paul IA (2006). Neonatal citalopram exposure produces lasting changes in behavior which are reversed by adult imipramine treatment. Eur J Pharmacol 532: 265-269.
59. Malberg JE, Duman RS (2003). Cell proliferation in adult hippocampus is decreased by inescapable stress: reversal by fluoxetine treatment. Neuropsychopharmacology 28: 1562-1571. (Pubitemid 41070856)
60. Malberg JE, Eisch AJ, Nestler EJ, Duman RS (2000). Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci 20: 9104-9110. (Pubitemid 32042912)
61. Mar A, Spreekmeester E, Rochford J (2000). Antidepressants preferentially enhance habituation to novelty in the olfactory bulbectomized rat. Psychopharmacology (Berl) 150: 52-60. (Pubitemid 30350813)
62. Maudhuit C, Hamon M, Adrien J (1995). Electrophysiological activity of raphe dorsalis serotoninergic neurones in a possible model of endogenous depression. Neuroreport 6: 681-684.
63. McGrath C, Norman TR (1998). The effect of venlafaxine treatment on the behavioural and neurochemical changes in the olfactory bulbectomised rat. Psychopharmacology (Berl) 136: 394-401. (Pubitemid 28189670)
64. McNish KA, Davis M (1997). Olfactory bulbectomy enhances sensitization of the acoustic startle reflex produced by acute or repeated stress. Behav Neurosci 111: 80-91. (Pubitemid 27097519)
65. Mirmiran M, Van de Poll NE, Corner MA, Van Oyen HG, Bour HL (1981). Suppression of active sleep by chronic treatment with chlorimipramine during early postnatal development: effects upon adult sleep and behavior in the rat. Brain Res 204: 129-146. (Pubitemid 11247494)
66. Mnie-Filali O, Faure C, El Mansari M, Lambas-Senas L, Berod A, Zimmer L et al (2007b). R-citalopram prevents the neuronal adaptive changes induced by escitalopram. NeuroReport 18: 1553-1556. (Pubitemid 47476382)
67. Mnie-Filali O, Lambas-Señas L, Scarna H, Haddjeri N (2009). Therapeutic potential of 5-HT receptors in mood disorders. Curr Drug Targets 10: 1109-1117.
68. Mnie-Filali O, Lambás-Señas L, Zimmer L, Haddjeri N (2007a). 5-HT7 receptor antagonists as a new class of antidepressants. Drug News Perspect 20: 613-618. (Pubitemid 351437589)
69. Monti JM, Leopoldo M, Jantos H (2008). The serotonin 5-HT7 receptor agonist LP-44 microinjected into the dorsal raphe nucleus suppresses REM sleep in the rat. Behav Brain Res 191: 184-189.
70. Montgomery SA (2002). Dopaminergic deficit and the role of amisulpride in the treatment of mood disorders. Int Clin Psychopharmacol 17(Suppl 4): S9-S17. (Pubitemid 36127066)
71. Moya PR, Berg KA, Gutiérrez-Hernandez MA, Sáez-Briones P, Reyes-Parada M, Cassels BK et al (2007). Functional selectivity of hallucinogenic phenethylamine and phenylisopropylamine derivatives at human 5-hydroxytryptamine (5-HT)2A and 5-HT2C receptors. J Pharmacol Exp Ther 321: 1054-1061. (Pubitemid 46762692)
72. Mullins UL, Gianutsos G, Eison AS (1999). Effects of antidepres-sants on 5-HT7 receptor regulation in the rat hypothalamus. Neuropsychopharmacology 21: 352-367. (Pubitemid 29333073)
73. Na YH, Hong SH, Lee JH, Park WK, Baek DJ, Koh HY et al (2008). Novel quinazolinone derivatives as 5-HT7 receptor ligands. Bioorg Med Chem 16: 2570-2578. (Pubitemid 351380927)
74. Nakagawasai O, Arai Y, Satoh SE, Satoh N, Neda M, Hozumi M et al (2004). Monoamine oxidase and head-twitch response in mice. Mechanisms of alpha-methylated substrate derivatives. Neurotoxicology 25: 223-232. (Pubitemid 38044184)
75. Nestler EJ, Barrot M, DiLeone RJ, Eisch AJ, Gold SJ, Monteggia LM (2002). Neurobiology of depression. Neuron 34: 13-25. (Pubitemid 34270695)
76. Ortmann R, Waldmeier PC, Radeke E, Felner A, Delini-Stula A (1980). The effects of 5-HT uptake- and MAO-inhibitors on L-5-HTP-induced excitation in rats. Naunyn Schmiedebergs Arch Pharmacol 311: 185-192. (Pubitemid 10156683)
77. Paxinos G, Watson C (1998). The Rat Brain in Stereotaxic Coordinates, Fourth Edition. Academic Press: New York.
78. Popa D, Cerdan J, Repérant C, Guiard BP, Guilloux JP, David DJ et al (2010). A longitudinal study of 5-HT outflow during chronic fluoxetine treatment using a new technique of chronic microdialysis in a highly emotional mouse strain. Eur J Pharmacol 628: 83-90.
79. Popa D, Léna C, Alexandre C, Adrien J (2008). Lasting syndrome of depression produced by reduction in serotonin uptake during postnatal development: evidence from sleep, stress, and behavior. J Neurosci 28: 3546-3554.
80. Porsolt RD, Bertin A, Jalfre M (1977). Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmaco-dyn Ther 229: 327-336. (Pubitemid 8225714)
81. Ranck JB (1975). Behavioral correlates and firing repertoires of neurons in the dorsal hippocampal formation and septum of unrestrained rats In: Isaacson RL, Pribram KH (eds). The Hippocampus. Plenum: New York. pp 207-244.
82. Romeas T, Morissette MC, Mnie-Filali O, Piñeyro G, Boye SM (2009). Simultaneous anhedonia and exaggerated locomotor activation in an animal model of depression. Psychopharmacol-ogy (Berl) 205: 293-303.
83. Ruat M, Traiffort E, Leurs R, Tardivel-Lacombe J, Diaz J, Arrang JM et al (1993). Molecular cloning, characterization, and localization of a high-affinity serotonin receptor (5-HT7) activating cAMP formation. Proc Natl Acad Sci USA 90: 8547-8551. (Pubitemid 23277706)
84. Sánchez C, Kreilgaard M (2004). R-citalopram inhibits functional and 5-HTP-evoked behavioural responses to the SSRI, escita-lopram. Pharmacol Biochem Behav 77: 391-398. (Pubitemid 38125173)
85. Santarelli L, Saxe M, Gross C, Surget A, Battaglia F, Dulawa S et al (2003). Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301: 805-809. (Pubitemid 36962615)
86. Sarkisyan G, Hedlund PB (2009). The 5-HT7 receptor is involved in allocentric spatial memory information processing. Behav Brain Res 202: 26-31.
87. Sarkisyan G, Roberts AJ, Hedlund PB (2010). The 5-HT receptor as a mediator and modulator of antidepressant-like behavior. Behav Brain Res 209: 99-108.
88. Schmitt A, Weber S, Jatzko A, Braus DF, Henn FA (2004). Hippocampal volume and cell proliferation after acute and chronic clozapine or haloperidol treatment. J Neural Transm 111: 91-100. (Pubitemid 38177820)
89. Shimomura K, Mori J, Honda F (1981). Backward walking induced by L-5-hydroxytryptophan in mice. Jpn J Pharmacol 31: 39-46. (Pubitemid 11150052)
90. Sleight AJ, Carolo C, Petit N, Zwingelstein C, Bourson A (1995). Identification of 5-hydroxytryptamine7 receptor binding sites in rat hypothalamus: sensitivity to chronic antidepressant treatment. Mol Pharmacol 47: 99-103.
91. Smeraldi E (1998). Amisulpride versus fluoxetine in patients with dysthymia or major depression in partial remission: a double-blind, comparative study. J Affect Disord 48: 47-56. (Pubitemid 28078970)
92. Song C, Leonard BE (2005). The olfactory bulbectomised rat as a model of depression. Neurosci Biobehav Rev 29: 627-647. (Pubitemid 40755458)
93. Stórustovu S, Sánchez C, Pörzgen P, Brennum LT, Larsen AK, Pulis M et al (2004). R-citalopram functionally antagonises escitalo-pram in vivo and in vitro: evidence for kinetic interaction at the serotonin transporter. Br J Pharmacol 142: 172-180. (Pubitemid 38698206)
94. Thomas DR, Melotto S, Massagrande M, Gribble AD, Jeffrey P, Stevens AJ et al (2003). SB-656104-A, a novel selective 5-HT7 receptor antagonist, modulates REM sleep in rats. Br J Pharmacol 139: 705-714. (Pubitemid 36819597)
95. To ZP, Bonhaus DW, Eglen RM, Jakeman LB (1995). Characterization and distribution of putative 5-ht7 receptors in guinea-pig brain. Br J Pharmacol 115: 107-116.
96. Van Oekelen D, Megens A, Meert T, Luyten WH, Leysen JE (2002). Role of 5-HT receptors in the tryptamine-induced 5-HT syndrome in rats. Behav Pharmacol 13: 313-318. (Pubitemid 35026257)
97. Van Riezen H, Leonard BE (1990). Effects of psychotropic drugs on the behavior and neurochemistry of olfactory bulbectomized rats. Pharmacol Ther 47: 21-34. (Pubitemid 20183306)
98. Vogel G, Hartley P, Neill D, Hagler M, Kors D (1988). Animal depression model by neonatal clomipramine: reduction of shock induced aggression. Pharmacol Biochem Behav 31: 103-106. (Pubitemid 19271189)
99. Wesolowska A, Nikiforuk A, Stachowicz K (2006). Potential anxiolytic and antidepressant effects of the selective 5-HT7 receptor antagonist SB 269970 after intrahippocampal administration to rats. Eur J Pharmacol 553: 185-190. (Pubitemid 44779615)
100. Wesołowska A, Kowalska M (2008). Influence of serotonin 5-HT receptor blockade on the behavioral and neurochemical effects of imipramine in rats. Pharmacol Rep 60: 464-474.
101. Willins DL, Meltzer HY (1997). Direct injection of 5-HT2A receptor agonists into the medial prefrontal cortex produces a head-twitch response in rats. J Pharmacol Exp Ther 282: 699-706. (Pubitemid 27340170)
102. Yau JL, Noble J, Seckl JR (2001). Acute restraint stress increases 5-HT7 receptor mRNA expression in the rat hippocampus. Neurosci Lett 309: 141-144. (Pubitemid 32763159)
103. Yoshioka M, Matsumoto M, Numazawa R, Togashi H, Smith CB, Saito H (1995). Changes in the regulation of 5-hydroxytrypta-mine release by alpha2-adrenoceptors in the rat hippocampus after long-term desipramine treatment. Eur J Pharmacol 294: 565-570. (Pubitemid 26013244)